Free shipping on all orders over $ 500

Pioglitazone

Cat. No. M3283

All AbMole products are for research use only, cannot be used for human consumption.

Pioglitazone Structure
Synonym:

U 72107

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
1mg USD 20  USD20 In stock
5mg USD 33  USD33 In stock
10mg USD 50  USD50 In stock
50mg USD 90  USD90 In stock
100mg USD 130  USD130 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Pioglitazone (U 72107) is a selective peroxisome proliferator-activated receptor gamma stimulator. Pioglitazone (U 72107) selectively stimulates the nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-γ) and to a lesser extent PPAR-α. Pioglitazone (Actos) modulates the transcription of the insulin-sensitive genes involved in the control of glucose and lipid metabolism in the muscle, adipose tissue, and the liver. As a result, pioglitazone (U 72107) reduces insulin resistance in the liver and peripheral tissues. Pioglitazone (U 72107) increases the expense of insulin-dependent glucose. Pioglitazone (U 72107) decreases withdrawal of glucose from the liver. Pioglitazone (U 72107) reduces quantity of glucose, insulin and glycated hemoglobin in the bloodstream.

Product Citations
Customer Product Validations & Biological Datas
Source J Cell Mol Med (2020 Jun). Figure 2. Pioglitazone (Abmole Bioscience, Houston, TX, USA)
Method drug treatments
Cell Lines Neurons
Concentrations 10 μmol/L
Incubation Time 24 hours
Results Compared to the DMSO group, a 24-hour treatment with pioglitazone increased the levels of the ZAG protein (1.013 ± 0.135 vs 0.654 ± 0.090, P = 0.004, n = 4) and AZGP1 mRNA (1.474 ± 0.078 vs 1, P = 0.003, n = 3) (Figure 2B,C), while GW9662 significantly decreased the levels of the ZAG protein (0.361 ± 0.097 vs 0.654 ± 0.090, P = 0.013, n = 4) and AZGP1 mRNA (0.482 ± 0.153 vs 1, P = 0.002, n = 3) (Figure 2B,C).
Chemical Information
Molecular Weight 356.44
Formula C19H20N2O3S
CAS Number 111025-46-8
Solubility (25°C) DMSO 30 mg/mL (Need ultrasonic and warming)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] David Karsek. Pioglitazone

[2] Ralph A DeFronzo, et al. Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes

[3] Huilin Tang, et al. Pioglitazone and bladder cancer risk: a systematic review and meta-analysis

[4] Sanjay Kalra, et al. Pioglitazone

[5] Hiroyoshi Yokoi. Pioglitazone

Related PPAR Products
GQ-16 

GQ-16 is a moderate affinity ligand for the ligand-binding domain (LBD) of PPARγ, exhibiting a Ki of 160 nM.

SR10221 

SR10221, a noncovalent inverse agonist of PPARγ, represses downstream PPARγ target genes leading to growth inhibition in bladder cancer cell lines.

Amorfrutin B 

Amorfrutin B is a highly potent natural peroxisome proliferation-activated receptor γ (PPARγ) agonist with oral activity with Ki values of 19 nM and EC50 values of 73 nM, respectively.

Netoglitazone

Netoglitazone is a dual agonist of PPARα and PPARγ with antihyperglycemic activity.

DSO-5a

DSO-5a is a potent, selective, orally active BB3 agonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: Pioglitazone, U 72107 supplier, PPAR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.